PSNY Earnings

PSNY reported its FY2025Q3 earnings on 2025-11-12, showcasing a revenue of 748.00M against an estimate of 850.00M, resulting in a -12% surprise. The EPS was -0.15, surpassing the expected 0 by 0%. The stock experienced a -15.36% price change on the earnings day and a -31.46% change over the next five days, reflecting market reactions to the results.

Following PSNY's FY2025Q3 earnings announcement on 2025-11-12, the stock price moved by -15.36% on the day of the release. Over the subsequent five days, it saw a -31.46% change. Historically, PSNY's stock price tends to shift by an average of -3.89% in the 10 days leading up to earnings and 3.44% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate PSNY's annual revenue to reach 814.90M, while the EPS is projected at -3.63. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between PSNY's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, PSNY's stock price typically moves by -3.89% in the 10 days before its earnings and 3.44% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -3.63 and revenue of 814.90M.

The earnings call reveals a mixed performance with some positive elements, such as revenue growth and improved adjusted EBITDA. However, significant concerns persist, including a negative gross margin due to impairment, high debt levels, and uncertainties in the U.S. market. The pause in financial guidance and lack of clarity on achieving EBITDA breakeven further dampen sentiment. Despite some positive strategic initiatives, these financial and operational challenges outweigh them, leading to a negative outlook for the stock price in the short term.